BHST BIOHARVEST SCIENCES INC.

NEUTRAL Impact: 2/10 6-K
Horizon weeks Filed May 11, 2026 Processed 1mo ago SEC 0001723464-26-000020
Notable filing: 6-K
Latest settled — T+5d ⚠ clustered
BHST ▲ +3.13% at T+5d
NEUTRAL call ✓ call won +3.13% · α vs SPY +3.05% · entry $3.84 → $3.96
Next anchor: T+20d due 4d ago
Currently $3.20 · -16.67% from $3.84 entry
Entry anchored
May 11, 2026
via day open
T+1d
0.00%
call 0.00% · α -0.54%
$3.84
settled 5w ago
T+5d
+3.13%
call +3.13% · α +3.05%
$3.96
settled 26d ago
T+20d
call — · α —
due 4d ago
T+60d
call — · α —
in 8w

Price Chart

Loading chart...

Executive Summary

BioHarvest Sciences announced a strategic leadership transition: Co-Founder and Executive Chairman Zaki Rakib succeeds Ilan Sobel as CEO, with Sobel moving to the Board. The change aims to sharpen execution across the D2C and CDMO businesses. No financial details or guidance were provided in the filing.

Actionable Insight

Leadership changes are routine and typically neutral. Monitor upcoming quarterly results for any strategic shifts or operational updates under the new CEO.

Key Facts

  • Zaki Rakib appointed CEO, effective April 29, 2026.
  • Ilan Sobel transitions from CEO to Board member, focusing on D2C business.
  • Rakib previously led CDMO and R&D; co-founded BioHarvest and former CEO of Terayon.
  • FY2025 revenue mentioned as approximately $35M (from material change report).

Financial Impact

No direct financial impact; revenue mentioned as ~$35M for FY2025.

Risk Factors

  • Execution risk from leadership transition.
  • Potential strategic pivot may not materialize as expected.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001723464-26-000020
Document: bhsc_ex991.htm0001723464-26-000020
Document: 0001723464-26-000020-index-headers.html0001723464-26-000020
Document: 0001723464-26-000020-index.html0001723464-26-000020
Document: 0001723464-26-000020.txt0001723464-26-000020
8 reports for BHST
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BHST — sortable, filterable
Type Now
May 28, 2026
15d ago
6-K
NEUTRAL ★ 3/10
$3.90 $3.56▼ −8.72%▼ −8.67%$3.20 (−17.95%)
May 14, 2026
29d ago
6-K
NEUTRAL ★ 5/10
$4.16 $3.82▼ −8.17%▼ −7.46%$3.20 (−23.08%)
May 14, 2026
29d ago
6-K
BEARISH ★ 6/10
$4.16 $3.82▲ +8.17%▲ +7.46%$3.20 (+23.08%)
May 14, 2026
29d ago
6-K
NEUTRAL ★ 3/10
$4.16 $3.82▼ −8.17%▼ −7.46%$3.20 (−23.08%)
May 12, 2026
4w ago
6-K
NEUTRAL ★ 4/10
$3.84 $3.96▲ +3.13%▲ +3.05%$3.20 (−16.67%)
May 11, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$3.84 $3.96▲ +3.13%▲ +3.05%$3.20 (−16.67%)
Apr 29, 2026
6w ago
6-K
NEUTRAL ★ 3/10
$4.25 $4.21▼ −0.94%▼ −4.05%$3.20 (−24.71%)
Mar 27, 2026
11w ago
6-K
BULLISH ★ 7/10
$4.32 $4.36▲ +0.93%▼ −2.94%$3.20 (−25.93%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (48h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access